$XWEL
XWELL Inc Stock $xwel

$xwel Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000114420415016329 Filed on March 16, 2015

Income Statement

Concept	2014 Q4	2014 Q3	2014
Revenue	$225.0K	$150.0K	$1.425M
YoY Change			29.55%
Cost Of Revenue	$5.650M	$8.870M	$0.00
YoY Change	-5.68%	31.9%	-100.0%
Gross Profit	-$5.420M	-$8.720M	$1.425M
YoY Change	-9.52%	29.67%	-106.95%
Gross Profit Margin	-2408.89%	-5813.33%	100.0%
Selling, General & Admin	$3.560M	$4.148M	$16.37M
YoY Change	-8.25%	9.13%	6.8%
% of Gross Profit			1148.98%
Research & Development	$220.0K	$230.0K	$889.0K
YoY Change	-4.35%	-57.56%	-41.2%
% of Gross Profit			62.39%
Depreciation & Amortization		$2.330M	$255.0K
YoY Change		170.93%	193.1%
% of Gross Profit			17.89%
Operating Expenses	$3.290M	$4.148M	$17.26M
YoY Change	-38.62%	-4.49%	2.49%
Operating Profit	-$75.82M	-$15.20M	-$111.2M
YoY Change	589.04%	44.46%	172.69%
Interest Expense	-$20.00K	$0.00	$0.00
YoY Change	-166.67%	-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	-$60.00K	$35.00K	$1.974M
YoY Change	-135.29%	16.67%	758.26%
Pretax Income	-$75.90M	-$12.38M	-$109.2M
YoY Change	602.13%	25.66%	161.62%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$76.14M	-$12.38M	-$109.7M
YoY Change	301.41%	17.2%	109.18%
Net Earnings / Revenue	-33841.33%	-8250.67%	-7696.63%
Basic Earnings Per Share	-$0.81	-$0.13	-$12.24
Diluted Earnings Per Share	-$0.82	-$0.16	-$12.36
COMMON SHARES
Basic Shares Outstanding	93.18M shares	92.62M shares	8.964M shares
Diluted Shares Outstanding		92.65M shares	9.049M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2014
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.00M	$24.30M	$16.00M
YoY Change	-52.38%	-40.88%	-52.38%
Cash & Equivalents	$16.02M	$24.29M	$16.00M
Short-Term Investments
Other Short-Term Assets	$510.0K	$3.600M	$2.600M
YoY Change	12.09%	414.29%	116.67%
Inventory	$0.00
Prepaid Expenses	$482.0K
Receivables	$0.00
Other Receivables
Total Short-Term Assets	$18.60M	$27.90M	$18.60M
YoY Change	-46.59%	-33.35%	-46.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$221.0K	$240.0K
YoY Change	-3.91%	-3.61%
Goodwill	$0.00	$65.76M
YoY Change	-100.0%	-0.32%
Intangibles	$17.63M	$18.49M
YoY Change	-22.52%	-39.1%
Long-Term Investments
YoY Change
Other Assets	$1.210M	$1.034M	$1.200M
YoY Change	389.88%		500.0%
Total Long-Term Assets	$18.84M	$85.50M	$18.80M
YoY Change	-78.83%	-11.51%	-78.88%
TOTAL ASSETS
Total Short-Term Assets	$18.60M	$27.90M	$18.60M
Total Long-Term Assets	$18.84M	$85.50M	$18.80M
Total Assets	$37.44M	$113.4M	$37.40M
YoY Change	-69.76%	-18.12%	-69.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.598M	$7.600M	$4.700M
YoY Change	-29.45%	90.0%	-7.84%
Accrued Expenses	$465.0K
YoY Change	55.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.732M	$7.558M	$4.700M
YoY Change	-13.78%	77.13%	-14.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.349M	$607.0K	$1.500M
YoY Change		-85.2%	-62.5%
Total Long-Term Liabilities	$1.349M	$607.0K	$1.500M
YoY Change		-85.2%	-62.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.732M	$7.558M	$4.700M
Total Long-Term Liabilities	$1.349M	$607.0K	$1.500M
Total Liabilities	$6.081M	$8.165M	$6.300M
YoY Change	10.81%	-2.8%	-33.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$185.7M	-$109.6M
YoY Change	144.26%
Common Stock	$93.00K
YoY Change	-88.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.18M	$104.9M	$31.20M
YoY Change
Total Liabilities & Shareholders Equity	$37.44M	$113.4M	$37.40M
YoY Change	-69.76%	-18.11%	-69.79%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2014
OPERATING ACTIVITIES
Net Income	-$76.14M	-$12.38M	-$109.7M
YoY Change	301.41%	17.2%	109.18%
Depreciation, Depletion And Amortization		$2.330M	$255.0K
YoY Change		170.93%	193.1%
Cash From Operating Activities	-$8.160M	-$7.260M	-$28.38M
YoY Change	33.99%	13.26%	20.95%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$100.0K	$246.0K
YoY Change	-100.0%		969.57%
Acquisitions
YoY Change
Other Investing Activities	-$100.0K	$0.00	-$2.400M
YoY Change	-120.83%	-100.0%	1163.16%
Cash From Investing Activities	-$100.0K	-$100.0K	-$2.650M
YoY Change	-89.47%	-104.08%	61.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	$13.45M
YoY Change	-100.0%	-100.0%	760.1%
NET CHANGE
Cash From Operating Activities	-8.160M	-7.260M	-$28.38M
Cash From Investing Activities	-100.0K	-100.0K	-$2.650M
Cash From Financing Activities	0.000	0.000	$13.45M
Net Change In Cash	-8.260M	-7.360M	-$17.58M
YoY Change	17.66%	167.64%	-25.31%
FREE CASH FLOW
Cash From Operating Activities	-$8.160M	-$7.260M	-$28.38M
Capital Expenditures	$0.00	-$100.0K	$246.0K
Free Cash Flow	-$8.160M	-$7.160M	-$28.63M
YoY Change	74.36%	11.7%	21.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><i>(b) Use of estimates</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill and the Company’s intangibles assets, the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties and other contingencies.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4732000	USD
CY2014Q4	us-gaap	Assets Assets	37435000	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5445000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	407000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76028000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185705000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	114282000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	31180000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	65757000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	123810000	USD
CY2014	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	37000	USD
CY2014	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>(e) Derivative instruments</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company recognizes all derivative instruments as either assets or liabilities in the consolidated balance sheets at their respective fair values. The Company's derivative instruments, which are discussed in Notes 9 and 11, have been recorded as liabilities at fair value, and are revalued at each reporting date, with changes in the fair value of the instruments included in the consolidated statements of operations as non-operating income (expense).</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>(q) Reclassification</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><i> </i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain balances have been reclassified to conform to presentation requirements including discontinued operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33586000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16023000	USD
CY2013Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	787000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2013Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	USD
CY2014Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2067000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	455000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17625000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	0	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	247000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	989000	USD
CY2013Q4	us-gaap	Assets Assets	123810000	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4731000	USD
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	43000	USD
CY2014Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5488000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4040000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	174000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	510000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	34828000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	18600000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	230000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	221000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22748000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1349000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	845000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	934000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	189465000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	215951000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37435000	USD
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84502653	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93404895	shares
CY2012	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	269000	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	224000	USD
CY2014Q1	vrng	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.0825	pure
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28213000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28213000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5465000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9233000	USD
CY2013	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2014	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1355000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22748000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17625000	USD
CY2014	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P8Y10M24D
CY2014Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1355000	USD
CY2013Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7045000	USD
CY2014Q3	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.14	pure
CY2014Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.95
CY2014Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.55
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15962585	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30859636	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25801945	shares
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	134000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	389000	USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84502653	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93404895	shares
CY2012	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	2666000	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	3334000	USD
CY2014	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	266000	USD
CY2012	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-2397000	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-10363000	USD
CY2014	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-229000	USD
CY2012	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	20000	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	-65000	USD
CY2014	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	20000	USD
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-2377000	USD
CY2012	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	55000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2432000	USD
CY2013Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	48000	USD
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-10428000	USD
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-209000	USD
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	257000	USD
CY2014	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	246000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-10685000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-455000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5212000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56960000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	7000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	34000	USD
CY2013Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1	0	USD
CY2013Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	102000	USD
CY2013Q4	us-gaap	Disposal Group Including Discontinued Operation Intangible Assets DisposalGroupIncludingDiscontinuedOperationIntangibleAssets	637000	USD
CY2013Q4	us-gaap	Goodwill Gross GoodwillGross	208000	USD
CY2013Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	4083000	USD
CY2014Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	175000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	156000	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	9000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	56000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	10657000	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	808000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	1707000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	7003000	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	430000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	2257000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7612000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4083000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	175000	USD
CY2013	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
CY2014	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
CY2013	vrng	Fair Value Inputs Probability Of Achieving Target FairValueInputsProbabilityOfAchievingTarget	0.05	pure
CY2014	vrng	Fair Value Inputs Probability Of Achieving Target FairValueInputsProbabilityOfAchievingTarget	0.5	pure
CY2013	vrng	Fair Value Assumptions Timing Of Down Round Triggering Event FairValueAssumptionsTimingOfDownRoundTriggeringEvent	December 2014
CY2014	vrng	Fair Value Assumptions Timing Of Down Round Triggering Event FairValueAssumptionsTimingOfDownRoundTriggeringEvent	June 2015
CY2012	us-gaap	Revenues Revenues	100000	USD
CY2013	us-gaap	Revenues Revenues	1100000	USD
CY2014	us-gaap	Revenues Revenues	1425000	USD
CY2012	us-gaap	Legal Fees LegalFees	10010000	USD
CY2013	us-gaap	Legal Fees LegalFees	21590000	USD
CY2014	us-gaap	Legal Fees LegalFees	25368000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1692000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3445000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5123000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	543000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1512000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	889000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10226000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15330000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15484000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	22471000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	41877000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	112621000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-22371000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-40777000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-111196000	USD
CY2012	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	-2000	USD
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	225000	USD
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	-162000	USD
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	6847000	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1196000	USD
CY2014	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2201000	USD
CY2012	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	-2883000	USD
CY2013	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	0	USD
CY2014	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	-65000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18409000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41748000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-109222000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.47
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-18409000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-41748000	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-109222000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-52433000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-109677000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	494666	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8052345	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6172691	shares
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-20841000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.23
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.77
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.92
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.53
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.28
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.36
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.04
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.50
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.22
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.06
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.13
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.01
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.55
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.50
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.23
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.06
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.13
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.01
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39111176	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83201691	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89640330	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41664676	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83280873	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90489740	shares
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8087000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12093000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10967000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10457159	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1300000	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1126815	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2083333	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.31
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.49
CY2014	vrng	Share Based Compensation Arrangement By Share Based Payment Award Vested Options Expired Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpiredWeightedAverageGrantDateFairValue	1.94
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.24
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5793420	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17402654	shares
CY2014Q4	vrng	Class Of Warrant Or Right Number Of Equity Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfEquityCalledByWarrantsOrRights	15801924	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1600730	shares
CY2014Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	10027000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	120000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	230000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	366000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	2865000	USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	974000	USD
CY2014	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2160000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2883000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	65000	USD
CY2012	vrng	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	22932000	USD
CY2013	vrng	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	1398000	USD
CY2014	vrng	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	12999000	USD
CY2014	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	384000	USD
CY2013	vrng	Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants	3918000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	148332000	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2501000	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5220000	USD
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4023000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-58000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	8087000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	12093000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	10967000	USD
CY2012	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2883000	USD
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	65000	USD
CY2012	vrng	Assignment Of Patents AssignmentOfPatents	0	USD
CY2013	vrng	Assignment Of Patents AssignmentOfPatents	100000	USD
CY2014	vrng	Assignment Of Patents AssignmentOfPatents	0	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-8000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	97000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-192000	USD
CY2012	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	208000	USD
CY2013	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	135000	USD
CY2014	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	-374000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3538000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	763000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14468000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23465000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28382000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	208000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	246000	USD
CY2012	us-gaap	Payments For Deposits PaymentsForDeposits	46000	USD
CY2013	us-gaap	Payments For Deposits PaymentsForDeposits	193000	USD
CY2014	us-gaap	Payments For Deposits PaymentsForDeposits	2404000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19476000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1636000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2650000	USD
CY2012	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	509000	USD
CY2013	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	974000	USD
CY2014	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2160000	USD
CY2012	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	12275000	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	590000	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11292000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	85694000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1564000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13452000	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2000	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	163000	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	17000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	51748000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-23374000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17563000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	787000	USD
CY2012	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	10657000	USD
CY2013	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	808000	USD
CY2014	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1707000	USD
CY2012	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	3918000	USD
CY2014	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2014	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 1. General</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>Overview</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Vringo, Inc., together with its consolidated subsidiaries (“Vringo” or the “Company”), is engaged in the development and monetization of intellectual property worldwide. The Company's intellectual property portfolio consists of over 600 patents and patent applications covering telecom infrastructure, internet search and mobile technologies. The Company’s patents and patent applications have been developed internally or acquired from third parties. In potential acquisitions, the Company seeks to purchase all of, or interests in, technology and intellectual property in exchange for cash, the Company’s securities and/or interests in the monetization of those assets. Revenue from this aspect of Vringo’s business can be generated through licensing and litigation efforts.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As further described in Note 7, Vringo closed a merger transaction (the “Merger”) with Innovate/Protect, Inc., a privately held corporation (“I/P”), on July 19, 2012. This transaction was accounted for as a reverse acquisition in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and as a result, I/P was deemed to be the acquiring company for accounting purposes. Accordingly, the Company’s financial statements for periods prior to the Merger reflect the historical results of I/P, and the Company’s financial statements for all periods from July 19, 2012 reflect the results of the combined company.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Prior to December 31, 2013, the Company operated a global platform for the distribution of mobile social applications and the services that it developed. On February 18, 2014, the Company executed the sale of its mobile social application business to InfoMedia Services Limited (“InfoMedia”), receiving an <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8.25</font>% ownership interest as consideration (Note 8). As part of the transaction, the Company will have the opportunity to license certain intellectual property assets and support InfoMedia to identify and protect new intellectual property.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><u>Infrastructure Patents</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On August 9, 2012, the Company entered into a patent purchase agreement with Nokia Corporation ("Nokia"), comprising of 124 patent families with counterparts in certain jurisdictions world-wide. The portfolio encompasses technologies relating to telecom infrastructure, including communication management, data and signal transmission, mobility management, radio resources management and services. Declarations were filed by Nokia indicating that 31 of the 124 patent families acquired may be essential to wireless communications standards. The Company also acquired certain patent portfolios during 2012 and 2013, and have filed over 60 internally developed patent applications since the Merger. As one of the means of realizing the value of the patents on telecom infrastructure, the Company has filed a number of suits against ZTE Corporation (“ZTE”), ASUSTeK Computer Inc. (“ASUS”), D-Link Corporation, and certain of their subsidiaries, affiliates and other companies in the United States, European jurisdictions, India, Australia, Brazil, and Malaysia alleging infringement of certain U.S., European, Indian, Australian, Brazilian, and Malaysian patents.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">To date, in connection with the filed suits against ZTE, Vringo patents have been found to be infringed in the United Kingdom and Germany, and preliminary relief has been granted in India, Brazil, Romania, and the Netherlands. Separately, Vringo has entered into settlement and license agreements with ADT, Tyco, and Belkin.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><u>Search Patents</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On September 15, 2011, the Company’s wholly-owned subsidiary, I/P Engine, Inc. (“I/P Engine”), initiated litigation against AOL Inc., Google, Inc., IAC Search & Media, Inc., Gannett Company, Inc., and Target Corporation (collectively, the "Defendants") for infringement of claims of certain of its owned patents. Trial commenced during 2012, and, on November 6, 2012, the jury ruled in favor of I/P Engine and against the Defendants. After upholding the validity of the patents-in-suit, and determining that the asserted claims of the patents were infringed by the Defendants, the jury found that reasonable royalty damages should be based on a "running royalty," and that the running royalty rate should be <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.5</font>%. The jury also awarded I/P Engine a total of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30.5</font> million. In January 2014, the United States District Court, Eastern District of Virginia (the “District Court”) ordered that I/P Engine recover an additional sum of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">17.32</font> million from the Defendants for supplemental damages and prejudgment interest. Further, the District Court ruled that the appropriate ongoing royalty rate for Defendants' continued infringement of the patents-in-suit is a rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6.5</font>% of the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20.9</font>% royalty base previously set by the District Court. These rulings were appealed by the Defendants and the oral argument was heard before the United States Court of Appeals for the Federal Circuit (“Federal Circuit”) on May 6, 2014.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On August 15, 2014, the Federal Circuit reversed the judgment of the District Court by holding that the asserted infringement claims by the Company of the patents-in-suit are invalid for obviousness. The Company filed a petition with the Federal Circuit on October 15, 2014 seeking en banc review of the decision. On October 20, 2014, the Federal Circuit invited the defendants/appellants to respond to the petition.  On December 15, 2014, the Federal Circuit denied I/P Engine's petition for rehearing of the case en banc and consequently, the Company announced that I/P Engine will seek review by the U.S. Supreme Court of the Federal Circuit’s decision.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><i>Financial conditions</i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of December 31, 2014, the Company had a cash balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">16,023</font>. The Company’s average monthly cash spent in operations for the years ended December 31, 2014 and 2013 was approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,365</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,955</font>, respectively. In addition, the Company paid approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,404</font> in deposits with courts during 2014 related to proceedings in Germany, Brazil, and Malaysia, which are included in Deposits with courts in the consolidated balance sheet as of December 31, 2014.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On June 19, 2014, the Company entered into agreements with certain of its warrant holders, pursuant to which the warrant holders exercised for cash <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,697,227</font> of their outstanding Series 1 and Series 2 warrants, with an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.76</font> per share. The Company granted such warrant holders unregistered warrants of the Company to purchase an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,412,366</font> shares of the Company’s common stock, par value $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.01</font> per share, at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.06</font> per share (the “June 2014 Warrants”). As a result of these transactions, the Company received $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,027</font> of proceeds. In addition, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,126,815</font> options to purchase 1,126,815 shares of the Company’s common stock were exercised during the year ended December 31, 2014. As a result, the Company received $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,160</font> of proceeds.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of December 31, 2014 and 2013, the Company’s total stockholders' equity was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">31,180</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">114,282</font>, respectively. The decrease in stockholders’ equity since December 31, 2013 is mainly due to the operating loss during the year ended 2014, which includes a non-cash goodwill impairment charge of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">65,757</font> that was recorded during the fourth quarter of 2014 in connection with the annual goodwill impairment test performed by the Company. As a result of the first step of the goodwill impairment test, it was determined that the fair value of the reporting unit did not exceed its carrying amount as of December 31, 2014, mainly due to the decline of the Company’s common stock price during the fourth quarter of 2014. Accordingly, the Company performed the second step of the goodwill impairment test and determined that the implied value of its goodwill was zero. Refer to Note 6 for further discussion of this impairment charge. <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company’s operating plans include efforts to increase revenue through the licensing of its intellectual property, strategic partnerships, and litigation, when required, which may be resolved through a settlement or collection. Disputes regarding the assertion of patents and other intellectual property rights are highly complex and technical. The majority of the Company’s expenditures consist of costs related to the Company’s four litigation campaigns. In the case against Google et al., the Company incurred costs during 2014 related to the preparation for the oral argument, which was heard before the Federal Circuit in May 2014, in addition to other related costs. In the cases against ZTE and ASUS, the Company incurred costs during 2014 related to the preparation and filing of briefs and other court documents, as well as case preparation and management. A large percentage of these costs were incurred in the United Kingdom, Australia, Germany, Brazil, the Netherlands, and France. In civil law jurisdictions, such as Germany, France, Spain, and others, the majority of costs are incurred in the early stages of litigation. With respect to the Company’s litigation in such countries, the respective campaigns are currently in the later stages and therefore the Company has already incurred the large majority of the related anticipated costs. As such, based on the Company’s plans, costs in these jurisdictions are projected to be lower in 2015 and other future periods. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Despite the Company’s plans, its legal proceedings may continue for several years and may require significant expenditures for legal fees and other expenses. Further, should the Company be deemed the losing party in certain of its litigations, it may be liable for some or all of its opponents’ legal fees. In addition, in connection with litigation, the Company has made several affirmative financial guarantees to courts around the world, and might face the need to make additional guarantees in the future. Refer to Note 14 for the Company’s disclosures of its commitments and contingencies for the assessments made by the Company with respect to legal fees and guarantees.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In addition, the Company’s plans to continue to expand its planned operations through acquisitions and monetization of additional patents, other intellectual property or operating businesses may be time consuming, complex and costly to consummate. The Company may utilize many different transaction structures in its acquisitions and the terms of such acquisition agreements tend to be heavily negotiated. The Company’s ability to raise capital may be limited. Even if the Company is able to acquire particular patents or other intellectual property assets, there is no guarantee that it will generate sufficient revenue related to those assets to offset the acquisition costs. Therefore, no assurance can be given at this time as to whether the Company will be able to achieve its objectives or whether it will have the sources of liquidity for follow through with its operating plans.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In addition, until the Company generates sufficient revenue, the Company may need to raise additional funds, which may be achieved through the issuance of additional equity or debt, or through loans from financial institutions. There can be no assurance, however, that any such opportunities will materialize. The Company may also be able to raise additional funds through the exercise of its outstanding warrants and options, however, substantially all of such outstanding equity instruments are currently “out of the money” due to the decline in the Company’s common stock price which began in the third quarter of 2014.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The circumstances discussed above raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s consolidated financial statements have been prepared assuming that it will continue as a going concern which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.</div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Entity Registrant Name EntityRegistrantName	Vringo Inc
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001410428
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q2	dei	Entity Public Float EntityPublicFloat	290632195	USD
CY2014	dei	Trading Symbol TradingSymbol	VRNG
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	93404895	shares
CY2012	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3326000	USD
CY2013	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22548000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-711000	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1420000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2878000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2806000	USD
CY2014	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	67112000	USD
CY2014	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3195000	USD
CY2013Q4	us-gaap	Cash Cash	24628000	USD
CY2014Q4	us-gaap	Cash Cash	2897000	USD
CY2013Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	3184000	USD
CY2014Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	13085000	USD
CY2013Q4	vrng	Currency Other Than Us Dollars CurrencyOtherThanUsDollars	5774000	USD
CY2014Q4	vrng	Currency Other Than Us Dollars CurrencyOtherThanUsDollars	41000	USD
CY2012	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2013	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	7253000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	76110000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2783000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2478000	USD
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3200000	USD
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3485000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	76000	USD
CY2012	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	54961000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	3326000	USD
CY2014Q4	vrng	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Excluding Cash And Cash Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsExcludingCashAndCashEquivalents	-740000	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	110000	USD
CY2012Q3	vrng	Gross Revenue By Portfolio Under Purchase Agreement GrossRevenueByPortfolioUnderPurchaseAgreement	22000000	USD
CY2012Q3	vrng	Capitalize Cost Related To Acquisition Of Patents CapitalizeCostRelatedToAcquisitionOfPatents	548000	USD
CY2012	vrng	Adjustment To Additional Paid In Capital Issuance Of Shares In Financing Round Three AdjustmentToAdditionalPaidInCapitalIssuanceOfSharesInFinancingRoundThree	31148000	USD
CY2012Q3	vrng	Royalty Payable On Excess Of Acquisition Cost RoyaltyPayableOnExcessOfAcquisitionCost	0.35	pure
CY2012Q4	vrng	Royalty Payable On Excess Of Acquisition Cost RoyaltyPayableOnExcessOfAcquisitionCost	0.2	pure
CY2012Q4	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	160600	shares
CY2012	vrng	Adjustment To Additonal Paidin Capital Issuance Of Shares In Financing Round Two AdjustmentToAdditonalPaidinCapitalIssuanceOfSharesInFinancingRoundTwo	44962000	USD
CY2012Q4	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	750000	USD
CY2012	vrng	Stock Issued During Period For Patents StockIssuedDuringPeriodForPatents	750000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	509000	USD
CY2013Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	208000	USD
CY2012	vrng	Purchase Patents PurchasePatents	750000	USD
CY2013	vrng	Purchase Patents PurchasePatents	0	USD
CY2014	vrng	Purchase Patents PurchasePatents	0	USD
CY2012	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	76000	USD
CY2013	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	0	USD
CY2014	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	0	USD
CY2012	vrng	Conversion Of Preferred Stockinto Common Stock Upon Merger ConversionOfPreferredStockintoCommonStockUponMerger	1724000	USD
CY2013	vrng	Conversion Of Preferred Stockinto Common Stock Upon Merger ConversionOfPreferredStockintoCommonStockUponMerger	0	USD
CY2014	vrng	Conversion Of Preferred Stockinto Common Stock Upon Merger ConversionOfPreferredStockintoCommonStockUponMerger	0	USD
CY2012	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	201000	USD
CY2013	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	0	USD
CY2014	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	0	USD
CY2013Q4	vrng	Computers Software And Equipment Gross ComputersSoftwareAndEquipmentGross	171000	USD
CY2014Q4	vrng	Computers Software And Equipment Gross ComputersSoftwareAndEquipmentGross	207000	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	83000	USD
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	201000	USD
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	202000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	364000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	610000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	87000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	255000	USD
CY2014Q4	vrng	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Deposit BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDeposit	8000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	3162000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	124000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	10133000	USD
CY2014Q4	vrng	Business Combination Consideration Transferred Stock Options Granted BusinessCombinationConsiderationTransferredStockOptionsGranted	7364000	USD
CY2014Q4	vrng	Business Combination Consideration Transferred Warrants Granted BusinessCombinationConsiderationTransferredWarrantsGranted	10079000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	78816000	USD
CY2014Q4	vrng	Businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedlongtermderivativeliability Businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedlongtermderivativeliability	3162000	USD
CY2014Q4	vrng	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill	65965000	USD
CY2014Q4	vrng	Business Combination Consideration Transferred Equity Interests Issued And Penny Options Granted BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndPennyOptionsGranted	58211000	USD
CY2014Q4	vrng	Business Acquisitions Cost Of Acquired Entity Purchase Price BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice	75654000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	75654000	USD
CY2012Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	463000	USD
CY2014Q4	vrng	Business Acquisition Purchases Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasesPriceAllocationAssetsAcquiredLiabilitiesAssumedNet	75654000	USD
CY2012	vrng	Disposal Group Including Discontinued Operation Impairment Loss DisposalGroupIncludingDiscontinuedOperationImpairmentLoss	0	USD
CY2013	vrng	Disposal Group Including Discontinued Operation Impairment Loss DisposalGroupIncludingDiscontinuedOperationImpairmentLoss	7253000	USD
CY2014	vrng	Disposal Group Including Discontinued Operation Impairment Loss DisposalGroupIncludingDiscontinuedOperationImpairmentLoss	0	USD
CY2013Q4	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	7253000	USD
CY2014	vrng	Deferred Foreign Income Tax Expense Benefit Discontinued Operations DeferredForeignIncomeTaxExpenseBenefitDiscontinuedOperations	0	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18409000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-41748000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Recorded In Connection With Merger FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRecordedInConnectionWithMerger	21954000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Derivative Warrants Issued By Legal Parent FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityDerivativeWarrantsIssuedByLegalParent	3162000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-17673000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-41204000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-108828000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-736000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-544000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-394000	USD
CY2012	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	65757000	USD
CY2013	vrng	Fair Value Measurement With Unobservable Input Sreconciliation Srecurring Basis Liability Derivative Warrants Removal FairValueMeasurementWithUnobservableInputSreconciliationSrecurringBasisLiabilityDerivativeWarrantsRemoval	2300000	USD
CY2012	vrng	Current Foreign Tax Expense Benefit Disontinued Operations CurrentForeignTaxExpenseBenefitDisontinuedOperations	112000	USD
CY2013	vrng	Current Foreign Tax Expense Benefit Disontinued Operations CurrentForeignTaxExpenseBenefitDisontinuedOperations	245000	USD
CY2014	vrng	Current Foreign Tax Expense Benefit Disontinued Operations CurrentForeignTaxExpenseBenefitDisontinuedOperations	246000	USD
CY2012	vrng	Deferred Foreign Income Tax Expense Benefit Discontinued Operations DeferredForeignIncomeTaxExpenseBenefitDiscontinuedOperations	-57000	USD
CY2013	vrng	Deferred Foreign Income Tax Expense Benefit Discontinued Operations DeferredForeignIncomeTaxExpenseBenefitDiscontinuedOperations	12000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-109222000	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2012	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	6443000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	14612000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	38228000	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-7461000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-10398000	USD
CY2014	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	8052345	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	6172691	shares
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-13864000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29918000	USD
CY2013	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	7253000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	416000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-15000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-6812000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-25070000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1197000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2714000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	793000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-164000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-116000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-87000	USD
CY2012	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	43558000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8104000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4789000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	38029000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	48688000	USD
CY2013Q4	vrng	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Intangible Assets DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsIntangibleAssets	7000	USD
CY2014Q4	vrng	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Intangible Assets DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsIntangibleAssets	341000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37758000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48688000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	264000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2012	vrng	Deferred Tax Assets Valuation Allowance Charged To Cost And Expenses DeferredTaxAssetsValuationAllowanceChargedToCostAndExpenses	12240000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3548000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2558000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	3200000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2445000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	USD
CY2012	vrng	Deferred Tax Assets Valuation Allowance Acquisitions DeferredTaxAssetsValuationAllowanceAcquisitions	10803000	USD
CY2012Q4	vrng	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAggregateIntrinsicValue	2417000	USD
CY2013Q4	vrng	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAggregateIntrinsicValue	1322000	USD
CY2014Q4	vrng	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedAggregateIntrinsicValue	2363000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M
CY2014Q4	vrng	Deferred Tax Assets Return To Provision Trueup DeferredTaxAssetsReturnToProvisionTrueup	3233000	USD
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	117000000	USD
CY2013Q2	vrng	Litigation Settlement Amount Description LitigationSettlementAmountDescription	According to the agreement, Microsoft Corporation paid the Company $1,000 and agreed to pay 5% of any future amount Google pays for its use of the patents acquired from Lycos.
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	370000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	347000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1943000	USD
CY2014	vrng	Average Monthly Cash Spent In Operations AverageMonthlyCashSpentInOperations	2365000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	403000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2014Q2	vrng	Warrants Exercised For Cash WarrantsExercisedForCash	5697227	shares
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-8158000	USD
CY2014Q2	vrng	Warrants Exercised For Cash Per Share WarrantsExercisedForCashPerShare	1.76
CY2014Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-246000	USD
CY2014	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	Shorter of the useful life of the asset or the term of the lease
CY2012Q4	vrng	Expected Term Of Warrants ExpectedTermOfWarrants	P2Y7M28D
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2173852	shares
CY2014Q4	us-gaap	Business Acquisition Share Price BusinessAcquisitionSharePrice	0.01
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24274000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1231000	USD
CY2014Q1	vrng	Royalty Rate RoyaltyRate	0.209	pure
CY2012Q4	vrng	Royalty Rate RoyaltyRate	0.035	pure
CY2014Q1	vrng	Supplemental Damages And Prejudgment Interest SupplementalDamagesAndPrejudgmentInterest	17320000	USD
CY2012Q4	vrng	Running Royalty Amount RunningRoyaltyAmount	30500000	USD
CY2014Q1	vrng	Ongoing Royalty Rate OngoingRoyaltyRate	0.065	pure
CY2013	vrng	Average Monthly Cash Spent In Operations AverageMonthlyCashSpentInOperations	1955000	USD
CY2014Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5412366	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.06
CY2014Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	10027000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2160000	USD
CY2014Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7575000	USD
CY2014Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	65757000	USD
CY2013Q4	vrng	Purchased Additional Patent Portfolio PurchasedAdditionalPatentPortfolio	1400000	USD
CY2013Q1	us-gaap	Revenues Revenues	0	USD
CY2014Q1	us-gaap	Revenues Revenues	250000	USD
CY2013Q2	us-gaap	Revenues Revenues	1100000	USD
CY2014Q2	us-gaap	Revenues Revenues	800000	USD
CY2013Q3	us-gaap	Revenues Revenues	0	USD
CY2014Q3	us-gaap	Revenues Revenues	150000	USD
CY2013Q4	us-gaap	Revenues Revenues	0	USD
CY2014Q4	us-gaap	Revenues Revenues	225000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10499000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9825000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8755000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10353000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10519000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15196000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-11004000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-75822000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10859000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10900000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10229000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10049000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9849000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12376000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10811000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-75897000	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1105000	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-209000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-711000	USD
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-11964000	USD
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-11109000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-10940000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-10049000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-10560000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-12376000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-18969000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-76143000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.82

Files In Submission

Name	View Source	Status
0001144204-15-016329-index-headers.html	Edgar Link	pending
0001144204-15-016329-index.html	Edgar Link	pending
0001144204-15-016329.txt	Edgar Link	pending
0001144204-15-016329-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v401376_10k.htm	Edgar Link	pending
v401376_ex21.htm	Edgar Link	pending
v401376_ex23-1.htm	Edgar Link	pending
v401376_ex23-2.htm	Edgar Link	pending
v401376_ex31-1.htm	Edgar Link	pending
v401376_ex31-2.htm	Edgar Link	pending
v401376_ex32.htm	Edgar Link	pending
vrng-20141231.xml	Edgar Link	completed
vrng-20141231.xsd	Edgar Link	pending
vrng-20141231_cal.xml	Edgar Link	unprocessable
vrng-20141231_def.xml	Edgar Link	unprocessable
vrng-20141231_lab.xml	Edgar Link	unprocessable
vrng-20141231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XWEL
XWELL Inc Stock $xwel

2014 Q4 Form 10-K Financial Statement

#000114420415016329 Filed on March 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XWEL XWELL Inc Stock $xwel

2014 Q4 Form 10-K Financial Statement

#000114420415016329 Filed on March 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XWEL
XWELL Inc Stock $xwel